Medical Cannabis Advocacy in East Asia During the 1960s

The short answer

There was no meaningful organized medical cannabis advocacy movement in East Asia during the 1960s. Strong evidence^[1] The decade was defined by the opposite trend: consolidation of postwar prohibition regimes, alignment with the 1961 Single Convention on Narcotic Drugs ^[1], and — in mainland China — the Cultural Revolution, which eliminated any independent civil-society drug policy debate.

Claims that the American or European counterculture had an East Asian medical cannabis analogue are not supported by primary historical records. This article addresses why the myth persists and what the actual legal and social landscape looked like across the region.

Japan: the Taima Torishimari Hō framework

Japan's Cannabis Control Act (大麻取締法, Taima Torishimari Hō) was enacted in 1948 during the U.S. occupation and remained the governing statute throughout the 1960s. Strong evidence^[2] The law criminalized cultivation, possession, and transfer of cannabis outside of licensed industrial hemp farming. Unlike the parallel Narcotics Control Act, which permitted medical opioids, the Cannabis Control Act included no medical use exception. Strong evidence^[2]

Throughout the 1960s, Japanese enforcement focused on suppressing residual traditional hemp cultivation and interdicting cannabis linked to U.S. military personnel stationed in Japan and Okinawa. Arrest numbers were small by later standards but trending upward. There is no record of a domestic Japanese organization, medical society, or public figure campaigning for medical cannabis access during this decade. Strong evidence

The romanticized narrative that Japan has a deep folk-medical cannabis tradition — sometimes invoked to imply 1960s advocacy — confuses pre-Meiji folk uses of hemp (taima, asa) with modern medical cannabis. These are distinct historical claims. Hemp fiber and seed held ritual and agricultural roles in Japanese culture, and some internal medicine texts reference hemp preparations, but documented clinical use in early-modern Japan is sparse. Disputed^[3] Critically, no 1960s revival or advocacy movement around historical cannabis medicine is documented in Japanese-language or English-language sources. Strong evidence

South Korea and Taiwan under authoritarian rule

South Korea did not pass a dedicated Cannabis Control Act until 1976, but cannabis was already regulated under pre-existing narcotics statutes during the 1960s. Strong evidence^[4] The political climate under the Park Chung-hee government was sharply hostile to drug liberalization and youth counterculture movements. Strong evidence^[4]

The well-known Korean cannabis crackdown associated with musician Shin Joong-hyun occurred in the mid-1970s, not the 1960s, and it was a prosecution wave, not an advocacy moment. Strong evidence^[4]

Taiwan under martial law similarly offered no political space for drug-policy advocacy of any kind during the 1960s. Cannabis fell under the Statute for Narcotics Hazard Control framework. The White Terror period (which lasted through the 1980s) meant that independent journalism, patient advocacy, and civil-society organizing on any sensitive topic — including drug policy — were not possible. Public debate on cannabis liberalization would have been politically impossible. Strong evidence

Mainland China during the Cultural Revolution

The People's Republic of China spent most of the 1960s consumed by the Cultural Revolution (1966–1976). Independent medical societies, patient advocacy groups, and reform journalism did not exist in any institutional form that could produce a drug policy debate. Strong evidence

China did continue licensed cultivation of industrial hemp (huoma, 火麻) for fiber and of hemp seed (huomaren, 火麻仁) as a traditional Chinese medicine laxative listed in the official pharmacopoeia. Strong evidence^[5] This is a continuation of centuries-old materia medica practice documented since at least the Tang Dynasty, not a 1960s medical cannabis advocacy movement. These two phenomena — traditional herbal use and modern reform — are frequently conflated in popular writing, creating a false impression of 1960s reform activity. Disputed

How the myth of 1960s East Asian advocacy spreads

Three recurring conflations create the false impression of 1960s East Asian medical cannabis advocacy:

1. Traditional herbal use is retroactively labeled 'advocacy.' The presence of hemp seed in Chinese pharmacopoeias, or of asa in Japanese Shinto ritual, is cited as if it were a modern reform position. It is not. These practices predate the 1960s by centuries and continued regardless of cannabis prohibition. Anecdote

2. Western counterculture is projected onto the region. Because the United States and parts of Western Europe saw cannabis-linked youth movements and cultural upheaval in the 1960s, writers sometimes assume East Asia had parallel movements. Primary sources — Japanese newspaper archives, Korean legal history, and PRC state media — do not support this assumption. Strong evidence^[6]

3. Later reform figures are backdated. Japan's small modern medical cannabis reform community, which became visible in the 2010s and led to the 2023 amendment of the Cannabis Control Act permitting cannabis-derived medicines, is sometimes described as having 'roots in the 1960s.' No documented organizational lineage supports this claim. Strong evidence^[7]

When encountering a specific claim about a 1960s East Asian medical cannabis campaign, the standard test is simple: ask for the primary source — a newspaper article, a petition, a legislative record, a named organization with a date. In our research for this entry, we did not find one. Strong evidence

What we don't know

There may be individual physicians, patients, or writers in 1960s Japan, Korea, Taiwan, or Hong Kong who privately advocated for medical cannabis and whose writings have not been digitized, translated, or catalogued in major archives. Absence of evidence in English-language and major Japanese-language sources is not logical proof of complete absence. No data

If a reader has access to verifiable primary sources — a dated publication, an identifiable named author, a preserved archival document, or a cited news article from the period — we would revise this entry. Until then, the accurate historical summary remains: no known organized medical cannabis advocacy in East Asia during the 1960s.

Sources

How this page was made

Related

• 1960s Counterculture and Cannabis — Cannabis as symbol and practice in the American counterculture, 1960–1972.
• 1961 Single Convention on Narcotic Drugs — The UN treaty that unified international drug control and shaped cannabis prohibition glob...
• Cannabis Activism in East Asia During the 1930s — Why organized cannabis activism was nearly absent in 1930s East Asia, and what was actuall...
• Cannabis Activism in East Asia During the 1970s — East Asia consolidated cannabis prohibition in the 1970s; no organized reform activism eme...
• Cannabis Culture in East Asia During the 1920s — Hemp remained an agricultural commodity in 1920s East Asia until international drug treati...